InterCure (NASDAQ:INCR) Shares Down 3.5% - Should You Sell?

Shares of InterCure Ltd. (NASDAQ:INCR - Get Free Report) were down 3.5% on Tuesday . The stock traded as low as $1.49 and last traded at $1.50. Approximately 34,007 shares changed hands during trading, an increase of 31% from the average daily volume of 25,980 shares. The stock had previously closed at $1.55.

InterCure Price Performance

The firm has a 50-day moving average of $1.52 and a two-hundred day moving average of $1.54. The company has a current ratio of 1.73, a quick ratio of 1.18 and a debt-to-equity ratio of 0.34.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in InterCure stock. Moore Capital Management LP purchased a new position in shares of InterCure Ltd. (NASDAQ:INCR - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 97,273 shares of the company's stock, valued at approximately $156,000. Moore Capital Management LP owned 0.21% of InterCure as of its most recent SEC filing. Institutional investors own 8.34% of the company's stock.

InterCure Company Profile

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.